Welcome to BioMarket Group!

Partneringreview 2006 - Stage of development (volume 4)

Additional Information

Published Date Feb 1, 2006
Special Offer No
Pages 1386
PDF Fact Sheet View Fact Sheet for the report Partneringreview 2006 - Stage of development (volume 4) in PDF format.
Published on Date No
Format No
Publisher N/A
Product Line No
Full Title No

Availability: In stock

$2,495.00

Quick Overview

Identify the latest dealmaking trends in stage of development
Request free sample pages from Partneringreview 2006 - Stage of development (volume 4)

Partneringreview 2006 – Volume 4: Stage of Development provides an in depth view into the deals and alliances by development stage announced in 2005, in a clear and accessible format.


The report reviews over 2,600 deal announcements from discovery stage deals to marketed – the full list of stages covered – discovery, lead molecule, preclinical, phase I, phase I/II, phase II, phase II/III, pre-registration, regulatory approval, marketing and formulation stage deals. Each sector is further divided to analyze deals by company, industry sector and therapy area.


Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed.


Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. When using the PDF format in Acrobat Reader, simply click on the number to move around the report.


All the year’s deals at a glance.


Want to know what your competitors are doing? Want to benchmark your deals against others in your therapeutic area or see how the finances of different deal types compare? Partneringreview 2006 brings all the 2005’s deals into focus in one place.Partneringreview is a comprehensive summary of the year’s deal announcements in a clear and accessible printable format. Every deal entry includes financial information where disclosed, such as headline values and upfront and milestone payments. A new addition of an overview of financings from investors is also included in this latest edition.

Request free sample pages from Partneringreview 2006 - Stage of development (volume 4)

Other selected research from the 'Business Development' category:


Datamonitor Healthcare Products Companies Report - Global Top 10 Pharmaceutical Companies
Top 10 Global Pharmaceutical Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the pharmaceutical industry and its top 10 companies. Learn More


Partneringreview 2006 Vol 2 Ch 13: Blood/Lymphatic System (PR06V2C13)
Identify the latest dealmaking trends in your field Learn More

Other selected research from the 'R&D' category:


Live-Licensing & In-life testing: R&D Processes and Regulation for New Drugs, 2008-2020
This report predicts that the current phase I to IV clinical testing process will eventually be selectively or wholly replaced by a system known as "in-life" testing or "live" licensing. Learn More


Vaccines Manufacturing Technology and Services: Commercial Prospects 2010-2025
Where you can find opportunities in this market.

Our new report will show you how the market for antithrombotic and anticoagulant drugs will develop. You can indentify where the greatest...
Learn More

Other selected research from the 'Markets' category:


Global Multiple Sclerosis Drug Market 2010-2025
The multiple sclerosis (MS) treatments market is one of the largest for CNS disorders, with total pharmaceutical revenues of over $8bn in 2009. Revenues for MS treatments will rise significantly... Learn More


Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025
In 2009, the biological (biologic) drug market generated over $125bn in revenues worldwide. There is great demand for lower-cost biological drugs. Commercial and regulatory developments will make biosimilars and... Learn More